시장보고서
상품코드
2127597

리보핵산(RNA) 프로브 시장 보고서(2026년)

Ribonucleic Acid (RNA) Probe Global Market Report 2026

발행일: | 리서치사: 구분자 The Business Research Company | 페이지 정보: 영문 250 Pages | 배송안내 : 2-10일 (영업일 기준)

    
    
    




■ 보고서에 따라 최신 정보로 업데이트하여 보내드립니다. 배송일정은 문의해 주시기 바랍니다.

가격
PDF & Excel (Single User License) help
PDF & Excel 보고서를 1명만 이용할 수 있는 라이선스입니다. 문서의 일부나 표는 Copy & Paste 가능합니다만 챕터 전체는 불가합니다. 문서의 일부나 표는 Copy & Paste 가능합니다만 챕터 전체는 불가합니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF·Excel 이용 범위와 동일합니다.
US $ 4,490 금액 안내 화살표 ₩ 6,285,000
PDF & Excel (Site License) help
PDF & Excel 보고서를 동일 기업의 동일 사업장 내의 모든 분이 이용할 수 있는 라이선스입니다. 문서의 일부나 표는 Copy & Paste 가능합니다만 챕터 전체는 불가합니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF·Excel 이용 범위와 동일합니다.
US $ 6,490 금액 안내 화살표 ₩ 9,085,000
PDF & Excel (Enterprise License) help
PDF & Excel 보고서를 동일 기업의 모든 분이 이용할 수 있는 라이선스입니다. 문서의 일부나 표는 Copy & Paste 가능합니다만 챕터 전체는 불가합니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF·Excel 이용 범위와 동일합니다.
US $ 8,490 금액 안내 화살표 ₩ 11,885,000
※ 부가세 별도
한글목차
영문목차

리보핵산(RNA) 프로브 시장 규모는 최근 강력하게 확대되고 있습니다. 시장 규모는 2025년 19억 1,000만 달러로 평가되었습니다. 2026년에는 20억 8,000만 달러로 확대되고, CAGR 9.3%로 성장할 전망입니다. 지난 몇 년간의 성장 요인으로는 분자진단 및 유전자 발현 연구의 진전, 형광 및 방사성 표지 프로브 기술의 개발, in situ 하이브리다이제이션 기술의 보급 확대, 암 유전체학 및 감염병 검사의 확대, 그리고 고특이성 핵산 검출법에 대한 수요 증가를 들 수 있습니다.

리보핵산(RNA) 프로브 시장 규모는 향후 몇 년간 강력한 성장을 보일 것으로 예측됩니다. 2030년에는 29억 2,000만 달러에 이르고, CAGR은 8.8%를 나타낼 전망입니다. 예측 기간 동안의 이러한 성장은 AI를 활용한 프로브 설계 및 서열 최적화 도구의 통합, 정밀 진단 및 맞춤형 의료에 대한 수요 증가, 공간 전사체학 및 단일 세포 분석 용도의 확대,다중화 및 고처리량 프로브 기반 분석법의 채택 확대, 그리고 첨단 이미징 및 분자 검출 기술의 발전에 기인한 것으로 보입니다. 예측 기간 동안의 주요 동향으로는 고감도 유전자 발현 검출을 위한 형광 멀티플렉스 RNA 프로브 기술의 통합, 정밀 분자진단 분야에서 맞춤형 합성 RNA 프로브의 채택 확대, 등온 증폭에 기반한 프로브 검출 시스템의 활용 확대,공간 전사체학을 위한 인시투(in situ) 하이브리드화 기술의 확대, 그리고 암 및 병원체 검출 워크플로우에서 효소 표지 프로브에 대한 수요 증가 등이 있습니다.

유전성 질환의 유병률 증가가 향후 리보핵산(RNA) 프로브 시장의 성장을 견인할 것으로 예측됩니다. 유전성 질환이란 개인의 DNA에 발생한 변화나 변이에 의해 유발되는 질환이나 상태를 말하며, 부모로부터 유전되는 경우도 있고 자연적으로 발생하는 경우도 있습니다. 진단 기술의 발전과 유전자 스크리닝 프로그램의 확대에 따라, 이전에는 진단되지 않았던 사례를 특정할 수 있게 됨에 따라 유전성 질환의 유병률은 증가하고 있습니다. 리보핵산(RNA) 프로브는 상보적인 메신저 RNA 서열에 특이적으로 결합하여 유전성 질환의 검출을 지원하며, 비정상적인 유전자 발현이나 유전자 변이를 특정함으로써 정밀한 분자진단을 가능하게 합니다. 예를 들어, 2025년 10월 기준으로 낭포성 섬유증 환자를 지원하는 영국의 자선 단체 ‘Cystic Fibrosis Trust’에 따르면, 낭포성 섬유증 환자 등록 수는 2022년 1만 1,148명, 2023년 1만 1,318명에서 2024년에는 1만 1,381명으로 증가하여 전년 대비 꾸준한 성장세를 보이고 있습니다. 따라서 유전성 질환의 유병률 증가가 리보핵산(RNA) 프로브 시장의 성장을 견인하고 있습니다.

리보핵산(RNA) 프로브 시장에서 사업을 전개하는 주요 기업들은 프로브의 품질 향상, 제품별 면역원성 최소화, 그리고 분자진단 및 연구 용도에서의 정확도 향상을 도모하기 위해 고신뢰도 RNA 합성 효소 등의 혁신적인 기술 개발에 주력하고 있습니다. 고충실도 RNA 합성 시스템은 기존의 RNA 중합효소를 이용한 합성법과 비교하여 불순물이 적고, 이중가닥 RNA(dsRNA)의 혼입을 대폭 저감한 RNA 분자를 생성하도록 설계된 첨단 분자생물학 기술입니다. dsRNA는 원치 않는 면역 반응을 유발하여 분석의 신뢰성을 저해할 우려가 있습니다. 예를 들어, 2024년 9월, 미국에 본사를 둔 Maravai LifeSciences 산하의 TriLink BioTechnologies Inc.는 마찬가지로 미국에 본사를 둔 생명공학 기업 Alphazyme LLC와 공동으로, RNA 합성의 품질을 대폭 향상시키기 위해 개발된 첨단 효소 ‘CleanScribe RNA 폴리메라제’를 발표했습니다. 이 효소는 체외 전사(IVT) 과정에서 이중가닥 RNA의 생성을 최대 85%까지 감소시켜, RNA 프로브 제조 및 mRNA 구조체 개발을 포함한 RNA 기반 응용 분야의 안전성과 성능을 향상시킵니다. 또한, 이 시스템은 프로토콜을 대폭 변경할 필요 없이 기존 IVT 워크플로우에 쉽게 통합될 수 있어, 연구개발용 및 치료용 RNA 제조 파이프라인 모두에 적합합니다. 아울러 이 기술은 재현성 향상과 고품질 RNA 생산을 가능하게 하여, 더욱 신뢰할 수 있는 하류 진단 및 유전체 응용 분야를 지원합니다.

자주 묻는 질문

  • 리보핵산(RNA) 프로브 시장 규모는 어떻게 변화하고 있나요?
  • 리보핵산(RNA) 프로브 시장의 성장 요인은 무엇인가요?
  • 유전성 질환의 유병률 증가가 리보핵산(RNA) 프로브 시장에 미치는 영향은 무엇인가요?
  • 리보핵산(RNA) 프로브 시장에서 주요 기업들은 어떤 기술 개발에 주력하고 있나요?
  • 리보핵산(RNA) 프로브의 안전성과 성능을 향상시키기 위한 기술은 무엇인가요?

목차

제1장 주요 요약

제2장 시장 특징

제3장 시장 공급망 분석

제4장 세계 시장 동향 및 전략

제5장 최종 이용 산업 시장 분석

제6장 시장 : 금리, 인플레이션, 지정학, 무역 전쟁과 관세의 영향, 관세 전쟁과 무역 보호주의의 공급망에 대한 영향, 코로나 팬데믹이 시장에 미치는 영향을 포함한 거시경제 시나리오

제7장 세계 전략 분석 프레임워크, 현재 시장 규모, 시장 비교 및 성장률 분석

제8장 TAM(Total Addressable Market) 규모

제9장 시장 세분화

제10장 지역 및 국가별 분석

제11장 아시아태평양 시장

제12장 중국 시장

제13장 인도 시장

제14장 일본 시장

제15장 호주 시장

제16장 인도네시아 시장

제17장 한국 시장

제18장 대만 시장

제19장 동남아시아 시장

제20장 서유럽 시장

제21장 영국 시장

제22장 독일 시장

제23장 프랑스 시장

제24장 이탈리아 시장

제25장 스페인 시장

제26장 동유럽 시장

제27장 러시아 시장

제28장 북미 시장

제29장 미국 시장

제30장 캐나다 시장

제31장 남미 시장

제32장 브라질 시장

제33장 중동 시장

제34장 아프리카 시장

제35장 시장 규제 상황 및 투자 환경

제36장 경쟁 구도 및 기업 개요

제37장 기타 주요 및 혁신 기업

제38장 세계 시장 경쟁 벤치마킹 및 대시보드

제39장 시장에서 주목 받는 스타트업

제40장 주요 인수합병(M&A)

제41장 시장 잠재력이 높은 국가, 부문, 전략

제42장 부록

KTH 26.09.16

Ribonucleic acid (RNA) probes are short, single-stranded RNA molecules specifically designed to selectively bind with complementary nucleic acid sequences for the detection, identification, or quantification of targeted RNA molecules. These probes are developed with precise nucleotide sequences and are commonly labeled with fluorescent, radioactive, or enzymatic markers to facilitate visualization and analytical detection. They are extensively used in molecular diagnostics and research applications for gene expression studies, pathogen identification, and genetic analysis with high specificity and sensitivity.

The primary product types of ribonucleic acid (RNA) probe include labeled ribonucleic acid probes, radiolabeled ribonucleic acid probes, biotinylated ribonucleic acid probes, digoxigenin-labeled ribonucleic acid probes, chemiluminescent ribonucleic acid probes, and custom or synthesized ribonucleic acid probes. Labeled ribonucleic acid probes refer to RNA molecules attached with detectable markers that are used for the identification and analysis of specific nucleic acid sequences. These products utilize technologies such as in situ hybridization, fluorescence in situ hybridization, polymerase chain reaction, and next-generation sequencing and are delivered through methods including microinjection, nanoliposomal delivery, viral vectors, and electroporation. The key applications include gene expression studies, molecular diagnostics, drug discovery and development, and cancer research, while the end-users include biotechnology companies, pharmaceutical companies, academic and research institutes, diagnostic laboratories, and contract research organizations.

Tariffs are influencing the ribonucleic acid (RNA) probes market by increasing the cost of imported labeled reagents, synthesis materials, and advanced detection instruments used in molecular diagnostics and research applications. This is affecting biotechnology companies, diagnostic laboratories, and academic research institutes, particularly in regions that depend on imported probe synthesis technologies, such as Asia-Pacific and Latin America. High-precision segments, including fluorescent and radiolabeled probes, are experiencing the greatest impact because of their reliance on specialized isotopes, enzymes, and imaging systems sourced globally. However, tariffs are encouraging local reagent manufacturing, strengthening regional supply chains, and increasing investment in domestic probe synthesis capabilities, thereby improving long-term market resilience and reducing import dependence.

The ribonucleic acid (rna) probe market research report is one of a series of new reports from The Business Research Company that provides ribonucleic acid (rna) probe market statistics, including ribonucleic acid (rna) probe industry global market size, regional shares, competitors with a ribonucleic acid (rna) probe market share, detailed ribonucleic acid (rna) probe market segments, market trends and opportunities, and any further data you may need to thrive in the ribonucleic acid (rna) probe industry. This ribonucleic acid (rna) probe market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The ribonucleic acid (RNA) probe market size has grown strongly in recent years. It will grow from $1.91 billion in 2025 to $2.08 billion in 2026 at a compound annual growth rate (CAGR) of 9.3%. The growth in the historic period can be attributed to growth in molecular diagnostics and gene expression research, development of fluorescent and radiolabeled probe technologies, increasing adoption of in situ hybridization techniques, expansion of cancer genomics and infectious disease testing, rising demand for high specificity nucleic acid detection methods.

The ribonucleic acid (RNA) probe market size is expected to see strong growth in the next few years. It will grow to $2.92 billion in 2030 at a compound annual growth rate (CAGR) of 8.8%. The growth in the forecast period can be attributed to integration of AI driven probe design and sequence optimization tools, increasing demand for precision diagnostics and personalized medicine, expansion of spatial transcriptomics and single cell analysis applications, rising adoption of multiplexed and high throughput probe based assays, growth in advanced imaging and molecular detection technologies. Major trends in the forecast period include integration of fluorescent multiplex rna probe technologies for high sensitivity gene expression detection, increasing adoption of custom synthesized rna probes for precision molecular diagnostics, growing use of isothermal amplification based probe detection systems, expansion of in situ hybridization techniques for spatial transcriptomics, rising demand for enzyme labeled probes in cancer and pathogen detection workflows.

The increasing prevalence of genetic disorders is expected to drive the growth of the ribonucleic acid (RNA) probe market going forward. Genetic disorders are diseases or conditions caused by alterations or mutations in an individual's DNA, which may be inherited from parents or arise spontaneously. The prevalence of genetic disorders is increasing due to advancements in diagnostic technologies and the expansion of genetic screening programs, enabling the identification of cases that previously remained undiagnosed. Ribonucleic acid (RNA) probes support the detection of genetic disorders by specifically binding to complementary messenger RNA sequences, allowing the identification of abnormal gene expression and genetic mutations for precise molecular diagnosis. For instance, in October 2025, according to the Cystic Fibrosis Trust, a UK-based charity dedicated to supporting people with cystic fibrosis, cystic fibrosis patient registrations rose from 11,148 in 2022 and 11,318 in 2023 to 11,381 in 2024, reflecting consistent year-over-year growth. Therefore, the increasing prevalence of genetic disorders is driving the growth of the ribonucleic acid (RNA) probe market.

Major companies operating in the ribonucleic acid (RNA) probe market are emphasizing the development of innovative technologies, such as high-fidelity RNA synthesis enzymes, to improve probe quality, minimize immunogenic byproducts, and enhance accuracy in molecular diagnostics and research applications. High-fidelity RNA synthesis systems are advanced molecular biology technologies designed to produce RNA molecules with greater purity and significantly lower double-stranded RNA (dsRNA) contamination, which can otherwise induce unwanted immune responses and compromise assay reliability compared to conventional RNA polymerase-based synthesis methods. For instance, in September 2024, TriLink BioTechnologies Inc., a US-based Maravai LifeSciences company, in collaboration with Alphazyme LLC, a US-based biotechnology company, introduced CleanScribe RNA Polymerase, an advanced enzyme developed to substantially enhance RNA synthesis quality. The enzyme decreases double-stranded RNA formation by up to 85% during in vitro transcription, improving the safety and performance of RNA-based applications, including RNA probe production and mRNA construct development. Furthermore, the system integrates easily into existing IVT workflows without requiring significant protocol modifications, making it well suited for both research and therapeutic RNA manufacturing pipelines. The technology also enables improved reproducibility and higher-quality RNA production, supporting more dependable downstream diagnostic and genomic applications.

In May 2024, Bruker Corporation, a US-based technology company, acquired the NanoString Technologies Inc. business for $392.6 million. Through this acquisition, Bruker sought to enhance its spatial biology and life sciences tools portfolio by incorporating NanoString's gene expression profiling and spatial transcriptomics platforms, thereby broadening its capabilities in advanced biological research, translational science, and multi-omics discovery workflows across academic and clinical research markets. NanoString Technologies Inc. is a US-based life sciences tools company specializing in target-specific hybridization probes for the detection and quantification of ribonucleic acid (RNA).

Major companies operating in the ribonucleic acid (RNA) probe market report are F. Hoffmann-La Roche Ltd., Thermo Fisher Scientific Inc., Merck KGaA, Danaher Corporation, Eurofins Scientific SE, Agilent Technologies Inc., Revvity Inc., QIAGEN N.V., Bio-Techne Corporation, GenScript Biotech Corporation, Takara Bio Inc., RiboBio Co. Ltd., Bio-Synthesis Inc., Biotage AB, Biolegio B.V., Ella Biotech GmbH, Baseclick GmbH, Geno Technology Inc., Enzo Biochem Inc., LGC Biosearch Technologies, Integrated DNA Technologies (IDT)

North America was the dominating region in the ribonucleic acid (RNA) probe market in 2025. Asia-Pacific is expected to be the rapidly growing region in the forecast period. The regions covered in the ribonucleic acid (RNA) probe market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the ribonucleic acid (RNA) probe market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The ribonucleic acid (RNA) probe market consists of sales of fluorescent RNA probes, gene expression detection probes, and pathogen detection RNA probes. Values in this market are 'factory gate' values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Ribonucleic Acid (RNA) Probe Market Global Report 2026 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses ribonucleic acid (rna) probe market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

  • Gain a truly global perspective with the most comprehensive report available on this market covering 16 geographies.
  • Assess the impact of key macro factors such as geopolitical conflicts, trade policies and tariffs, inflation and interest rate fluctuations, and evolving regulatory landscapes.
  • Create regional and country strategies on the basis of local data and analysis.
  • Identify growth segments for investment.
  • Outperform competitors using forecast data and the drivers and trends shaping the market.
  • Understand customers based on end user analysis.
  • Benchmark performance against key competitors based on market share, innovation, and brand strength.
  • Evaluate the total addressable market (TAM) and market attractiveness scoring to measure market potential.
  • Suitable for supporting your internal and external presentations with reliable high-quality data and analysis
  • Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
  • All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for ribonucleic acid (rna) probe ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The ribonucleic acid (rna) probe market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, total addressable market (TAM), market attractiveness score (MAS), competitive landscape, market shares, company scoring matrix, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

  • The market characteristics section of the report defines and explains the market. This section also examines key products and services offered in the market, evaluates brand-level differentiation, compares product features, and highlights major innovation and product development trends.
  • The supply chain analysis section provides an overview of the entire value chain, including key raw materials, resources, and supplier analysis. It also provides a list competitor at each level of the supply chain.
  • The updated trends and strategies section analyses the shape of the market as it evolves and highlights emerging technology trends such as digital transformation, automation, sustainability initiatives, and AI-driven innovation. It suggests how companies can leverage these advancements to strengthen their market position and achieve competitive differentiation.
  • The regulatory and investment landscape section provides an overview of the key regulatory frameworks, regularity bodies, associations, and government policies influencing the market. It also examines major investment flows, incentives, and funding trends shaping industry growth and innovation.
  • The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
  • The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.
  • The total addressable market (TAM) analysis section defines and estimates the market potential compares it with the current market size, and provides strategic insights and growth opportunities based on this evaluation.
  • The market attractiveness scoring section evaluates the market based on a quantitative scoring framework that considers growth potential, competitive dynamics, strategic fit, and risk profile. It also provides interpretive insights and strategic implications for decision-makers.
  • Market segmentations break down the market into sub markets.
  • The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth.
  • Expanded geographical coverage includes Taiwan and Southeast Asia, reflecting recent supply chain realignments and manufacturing shifts in the region. This section analyzes how these markets are becoming increasingly important hubs in the global value chain.
  • The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
  • The company scoring matrix section evaluates and ranks leading companies based on a multi-parameter framework that includes market share or revenues, product innovation, and brand recognition.

Scope

  • Markets Covered:1) By Product Type: Labeled Ribonucleic Acid Probes; Radiolabeled Ribonucleic Acid Probes; Biotinylated Ribonucleic Acid Probes; Digoxigenin Labeled Ribonucleic Acid Probes; Chemiluminescent Ribonucleic Acid Probes; Custom Or Synthesized Ribonucleic Acid Probes
  • 2) By Technology: In Situ Hybridization; Fluorescence In Situ Hybridization; Polymerase Chain Reaction; Next Generation Sequencing
  • 3) By Delivery Method: Microinjection; Nanoliposomal Delivery; Viral Vectors; Electroporation
  • 4) By Application: Gene Expression Studies; Molecular Diagnostics; Drug Discovery And Development; Cancer Research
  • 5) By End User: Biotechnology Companies; Pharmaceutical Companies; Academic And Research Institutes; Diagnostic Laboratories; Contract Research Organizations
  • Subsegments:
  • 1) By Labeled Ribonucleic Acid Probes: Fluorescent Labeled Ribonucleic Acid Probes; Enzyme Labeled Ribonucleic Acid Probes; Hapten Labeled Ribonucleic Acid Probes; Radioisotope Labeled Ribonucleic Acid Probes; Multiplex Or Dual Labeled Ribonucleic Acid Probes
  • 2) By Radiolabeled Ribonucleic Acid Probes: Phosphorus Thirty Two Labeled Probes; Sulfur Thirty Five Labeled Probes; Tritium Labeled Probes; Iodine One Hundred Twenty Five Labeled Probes; Single End Or Internally Radiolabeled Probes
  • 3) By Biotinylated Ribonucleic Acid Probes: Single Biotin Labeled Probes; Multiple Biotin Labeled Probes; Terminal Biotin Labeled Probes; Internal Biotin Labeled Probes; Streptavidin Based Detection Format Probes
  • 4) By Digoxigenin Labeled Ribonucleic Acid Probes: Single Digoxigenin Labeled Probes; Dual Digoxigenin Labeled Probes; Terminal Digoxigenin Modified Probes; Internal Digoxigenin Incorporated Probes; Anti Digoxigenin Antibody Detection Based Probes
  • 5) By Chemiluminescent Ribonucleic Acid Probes: Horseradish Peroxidase Based Chemiluminescent Probes; Alkaline Phosphatase Based Probes; Luminol Based Detection Probes; Chlorophenolred Beta D Galactopyranoside Or Chlorophenolred Beta D Galactopyranoside Star Substrate Based Probes; Direct Or Amplified Chemiluminescent Signal Probes
  • 6) By Custom Or Synthesized Ribonucleic Acid Probes: In Vitro Transcription Derived Ribonucleic Acid Probes; Synthetic Oligonucleotide Ribonucleic Acid Probes; Polymerase Chain Reaction Generated Ribonucleic Acid Probes; Full Length Or Fragment Ribonucleic Acid Probes; Application Specific Probes
  • Companies Mentioned: F. Hoffmann-La Roche Ltd.; Thermo Fisher Scientific Inc.; Merck KGaA; Danaher Corporation; Eurofins Scientific SE; Agilent Technologies Inc.; Revvity Inc.; QIAGEN N.V.; Bio-Techne Corporation; GenScript Biotech Corporation; Takara Bio Inc.; RiboBio Co. Ltd.; Bio-Synthesis Inc.; Biotage AB; Biolegio B.V.; Ella Biotech GmbH; Baseclick GmbH; Geno Technology Inc.; Enzo Biochem Inc.; LGC Biosearch Technologies; Integrated DNA Technologies (IDT)
  • Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Taiwan; Russia; South Korea; UK; USA; Canada; Italy; Spain
  • Regions: Asia-Pacific; South East Asia; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
  • Time Series: Five years historic and ten years forecast.
  • Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
  • Data Segmentations: country and regional historic and forecast data, market share of competitors, market segments.
  • Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
  • Delivery Format: Word, PDF or Interactive Report
  • + Excel Dashboard
  • Added Benefits
  • Bi-Annual Data Update
  • Customisation
  • Expert Consultant Support

Added Benefits available all on all list-price licence purchases, to be claimed at time of purchase. Customisations within report scope and limited to 20% of content and consultant support time limited to 8 hours.

Table of Contents

1. Executive Summary

  • 1.1. Key Market Insights (2020-2035)
  • 1.2. Visual Dashboard: Market Size, Growth Rate, Hotspots
  • 1.3. Major Factors Driving the Market
  • 1.4. Top Three Trends Shaping the Market

2. Ribonucleic Acid (RNA) Probe Market Characteristics

  • 2.1. Market Definition & Scope
  • 2.2. Market Segmentations
  • 2.3. Overview of Key Products and Services
  • 2.4. Global Ribonucleic Acid (RNA) Probe Market Attractiveness Scoring And Analysis
    • 2.4.1. Overview of Market Attractiveness Framework
    • 2.4.2. Quantitative Scoring Methodology
    • 2.4.3. Factor-Wise Evaluation
  • Growth Potential Analysis, Competitive Dynamics Assessment, Strategic Fit Assessment And Risk Profile Evaluation
    • 2.4.4. Market Attractiveness Scoring and Interpretation
    • 2.4.5. Strategic Implications and Recommendations

3. Ribonucleic Acid (RNA) Probe Market Supply Chain Analysis

  • 3.1. Overview of the Supply Chain and Ecosystem
  • 3.2. List Of Key Raw Materials, Resources & Suppliers
  • 3.3. List Of Major Distributors and Channel Partners
  • 3.4. List Of Major End Users

4. Global Ribonucleic Acid (RNA) Probe Market Trends And Strategies

  • 4.1. Key Technologies & Future Trends
    • 4.1.1 Biotechnology, Genomics & Precision Medicine
    • 4.1.2 Artificial Intelligence & Autonomous Intelligence
    • 4.1.3 Digitalization, Cloud, Big Data & Cybersecurity
    • 4.1.4 Industry 4.0 & Intelligent Manufacturing
    • 4.1.5 Internet of Things (IoT), Smart Infrastructure & Connected Ecosystems
  • 4.2. Major Trends
    • 4.2.1 Integration Of Fluorescent Multiplex Rna Probe Technologies For High Sensitivity Gene Expression Detection
    • 4.2.2 Increasing Adoption Of Custom Synthesized Rna Probes For Precision Molecular Diagnostics
    • 4.2.3 Growing Use Of Isothermal Amplification Based Probe Detection Systems
    • 4.2.4 Expansion Of In Situ Hybridization Techniques For Spatial Transcriptomics
    • 4.2.5 Rising Demand Of Enzyme Labeled Probes In Cancer And Pathogen Detection Workflows

5. Ribonucleic Acid (RNA) Probe Market Analysis Of End Use Industries

  • 5.1 Biotechnology Companies
  • 5.2 Pharmaceutical Companies
  • 5.3 Academic And Research Institutes
  • 5.4 Diagnostic Laboratories
  • 5.5 Contract Research Organizations

6. Ribonucleic Acid (RNA) Probe Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, Supply Chain Impact from Tariff War & Trade Protectionism, And Covid And Recovery On The Market

7. Global Ribonucleic Acid (RNA) Probe Strategic Analysis Framework, Current Market Size, Market Comparisons And Growth Rate Analysis

  • 7.1. Global Ribonucleic Acid (RNA) Probe PESTEL Analysis (Political, Economical, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
  • 7.2. Global Ribonucleic Acid (RNA) Probe Market Size, Comparisons And Growth Rate Analysis
  • 7.3. Global Ribonucleic Acid (RNA) Probe Historic Market Size and Growth, 2020 - 2025, Value ($ Billion)
  • 7.4. Global Ribonucleic Acid (RNA) Probe Forecast Market Size and Growth, 2025 - 2030, 2035F, Value ($ Billion)

8. Global Ribonucleic Acid (RNA) Probe Total Addressable Market (TAM) Analysis for the Market

  • 8.1. Definition and Scope of Total Addressable Market (TAM)
  • 8.2. Methodology and Assumptions
  • 8.3. Global Total Addressable Market (TAM) Estimation
  • 8.4. TAM vs. Current Market Size Analysis
  • 8.5. Strategic Insights and Growth Opportunities from TAM Analysis

9. Ribonucleic Acid (RNA) Probe Market Segmentation

  • 9.1. Global Ribonucleic Acid (RNA) Probe Market, Segmentation By Product Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Labeled Ribonucleic Acid Probes, Radiolabeled Ribonucleic Acid Probes, Biotinylated Ribonucleic Acid Probes, Digoxigenin Labeled Ribonucleic Acid Probes, Chemiluminescent Ribonucleic Acid Probes, Custom Or Synthesized Ribonucleic Acid Probes
  • 9.2. Global Ribonucleic Acid (RNA) Probe Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • In Situ Hybridization, Fluorescence In Situ Hybridization, Polymerase Chain Reaction, Next Generation Sequencing
  • 9.3. Global Ribonucleic Acid (RNA) Probe Market, Segmentation By Delivery Method, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Microinjection, Nanoliposomal Delivery, Viral Vectors, Electroporation
  • 9.4. Global Ribonucleic Acid (RNA) Probe Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Gene Expression Studies, Molecular Diagnostics, Drug Discovery And Development, Cancer Research
  • 9.5. Global Ribonucleic Acid (RNA) Probe Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Biotechnology Companies, Pharmaceutical Companies, Academic And Research Institutes, Diagnostic Laboratories, Contract Research Organizations
  • 9.6. Global Ribonucleic Acid (RNA) Probe Market, Sub-Segmentation Of Labeled Ribonucleic Acid Probes, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Fluorescent Labeled Ribonucleic Acid Probes, Enzyme Labeled Ribonucleic Acid Probes, Hapten Labeled Ribonucleic Acid Probes, Radioisotope Labeled Ribonucleic Acid Probes, Multiplex Or Dual Labeled Ribonucleic Acid Probes
  • 9.7. Global Ribonucleic Acid (RNA) Probe Market, Sub-Segmentation Of Radiolabeled Ribonucleic Acid Probes, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Phosphorus Thirty Two Labeled Probes, Sulfur Thirty Five Labeled Probes, Tritium Labeled Probes, Iodine One Hundred Twenty Five Labeled Probes, Single End Or Internally Radiolabeled Probes
  • 9.8. Global Ribonucleic Acid (RNA) Probe Market, Sub-Segmentation Of Biotinylated Ribonucleic Acid Probes, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Single Biotin Labeled Probes, Multiple Biotin Labeled Probes, Terminal Biotin Labeled Probes, Internal Biotin Labeled Probes, Streptavidin Based Detection Format Probes
  • 9.9. Global Ribonucleic Acid (RNA) Probe Market, Sub-Segmentation Of Digoxigenin Labeled Ribonucleic Acid Probes, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Single Digoxigenin Labeled Probes, Dual Digoxigenin Labeled Probes, Terminal Digoxigenin Modified Probes, Internal Digoxigenin Incorporated Probes, Anti Digoxigenin Antibody Detection Based Probes
  • 9.10. Global Ribonucleic Acid (RNA) Probe Market, Sub-Segmentation Of Chemiluminescent Ribonucleic Acid Probes, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Horseradish Peroxidase Based Chemiluminescent Probes, Alkaline Phosphatase Based Probes, Luminol Based Detection Probes, Chlorophenolred Beta D Galactopyranoside Or Chlorophenolred Beta D Galactopyranoside Star Substrate Based Probes, Direct Or Amplified Chemiluminescent Signal Probes
  • 9.11. Global Ribonucleic Acid (RNA) Probe Market, Sub-Segmentation Of Custom Or Synthesized Ribonucleic Acid Probes, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • In Vitro Transcription Derived Ribonucleic Acid Probes, Synthetic Oligonucleotide Ribonucleic Acid Probes, Polymerase Chain Reaction Generated Ribonucleic Acid Probes, Full Length Or Fragment Ribonucleic Acid Probes, Application Specific Probes

10. Ribonucleic Acid (RNA) Probe Market Regional And Country Analysis

  • 10.1. Global Ribonucleic Acid (RNA) Probe Market, Split By Region, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • 10.2. Global Ribonucleic Acid (RNA) Probe Market, Split By Country, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

11. Asia-Pacific Ribonucleic Acid (RNA) Probe Market

  • 11.1. Asia-Pacific Ribonucleic Acid (RNA) Probe Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 11.2. Asia-Pacific Ribonucleic Acid (RNA) Probe Market, Segmentation By Product Type, Segmentation By Technology, Segmentation By Delivery Method, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

12. China Ribonucleic Acid (RNA) Probe Market

  • 12.1. China Ribonucleic Acid (RNA) Probe Market Overview
  • Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 12.2. China Ribonucleic Acid (RNA) Probe Market, Segmentation By Product Type, Segmentation By Technology, Segmentation By Delivery Method, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

13. India Ribonucleic Acid (RNA) Probe Market

  • 13.1. India Ribonucleic Acid (RNA) Probe Market, Segmentation By Product Type, Segmentation By Technology, Segmentation By Delivery Method, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

14. Japan Ribonucleic Acid (RNA) Probe Market

  • 14.1. Japan Ribonucleic Acid (RNA) Probe Market Overview
  • Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 14.2. Japan Ribonucleic Acid (RNA) Probe Market, Segmentation By Product Type, Segmentation By Technology, Segmentation By Delivery Method, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

15. Australia Ribonucleic Acid (RNA) Probe Market

  • 15.1. Australia Ribonucleic Acid (RNA) Probe Market, Segmentation By Product Type, Segmentation By Technology, Segmentation By Delivery Method, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

16. Indonesia Ribonucleic Acid (RNA) Probe Market

  • 16.1. Indonesia Ribonucleic Acid (RNA) Probe Market, Segmentation By Product Type, Segmentation By Technology, Segmentation By Delivery Method, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

17. South Korea Ribonucleic Acid (RNA) Probe Market

  • 17.1. South Korea Ribonucleic Acid (RNA) Probe Market Overview
  • Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 17.2. South Korea Ribonucleic Acid (RNA) Probe Market, Segmentation By Product Type, Segmentation By Technology, Segmentation By Delivery Method, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

18. Taiwan Ribonucleic Acid (RNA) Probe Market

  • 18.1. Taiwan Ribonucleic Acid (RNA) Probe Market Overview
  • Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 18.2. Taiwan Ribonucleic Acid (RNA) Probe Market, Segmentation By Product Type, Segmentation By Technology, Segmentation By Delivery Method, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

19. South East Asia Ribonucleic Acid (RNA) Probe Market

  • 19.1. South East Asia Ribonucleic Acid (RNA) Probe Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 19.2. South East Asia Ribonucleic Acid (RNA) Probe Market, Segmentation By Product Type, Segmentation By Technology, Segmentation By Delivery Method, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

20. Western Europe Ribonucleic Acid (RNA) Probe Market

  • 20.1. Western Europe Ribonucleic Acid (RNA) Probe Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 20.2. Western Europe Ribonucleic Acid (RNA) Probe Market, Segmentation By Product Type, Segmentation By Technology, Segmentation By Delivery Method, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

21. UK Ribonucleic Acid (RNA) Probe Market

  • 21.1. UK Ribonucleic Acid (RNA) Probe Market, Segmentation By Product Type, Segmentation By Technology, Segmentation By Delivery Method, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

22. Germany Ribonucleic Acid (RNA) Probe Market

  • 22.1. Germany Ribonucleic Acid (RNA) Probe Market, Segmentation By Product Type, Segmentation By Technology, Segmentation By Delivery Method, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

23. France Ribonucleic Acid (RNA) Probe Market

  • 23.1. France Ribonucleic Acid (RNA) Probe Market, Segmentation By Product Type, Segmentation By Technology, Segmentation By Delivery Method, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

24. Italy Ribonucleic Acid (RNA) Probe Market

  • 24.1. Italy Ribonucleic Acid (RNA) Probe Market, Segmentation By Product Type, Segmentation By Technology, Segmentation By Delivery Method, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

25. Spain Ribonucleic Acid (RNA) Probe Market

  • 25.1. Spain Ribonucleic Acid (RNA) Probe Market, Segmentation By Product Type, Segmentation By Technology, Segmentation By Delivery Method, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

26. Eastern Europe Ribonucleic Acid (RNA) Probe Market

  • 26.1. Eastern Europe Ribonucleic Acid (RNA) Probe Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 26.2. Eastern Europe Ribonucleic Acid (RNA) Probe Market, Segmentation By Product Type, Segmentation By Technology, Segmentation By Delivery Method, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

27. Russia Ribonucleic Acid (RNA) Probe Market

  • 27.1. Russia Ribonucleic Acid (RNA) Probe Market, Segmentation By Product Type, Segmentation By Technology, Segmentation By Delivery Method, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

28. North America Ribonucleic Acid (RNA) Probe Market

  • 28.1. North America Ribonucleic Acid (RNA) Probe Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 28.2. North America Ribonucleic Acid (RNA) Probe Market, Segmentation By Product Type, Segmentation By Technology, Segmentation By Delivery Method, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

29. USA Ribonucleic Acid (RNA) Probe Market

  • 29.1. USA Ribonucleic Acid (RNA) Probe Market Overview
  • Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 29.2. USA Ribonucleic Acid (RNA) Probe Market, Segmentation By Product Type, Segmentation By Technology, Segmentation By Delivery Method, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

30. Canada Ribonucleic Acid (RNA) Probe Market

  • 30.1. Canada Ribonucleic Acid (RNA) Probe Market Overview
  • Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 30.2. Canada Ribonucleic Acid (RNA) Probe Market, Segmentation By Product Type, Segmentation By Technology, Segmentation By Delivery Method, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

31. South America Ribonucleic Acid (RNA) Probe Market

  • 31.1. South America Ribonucleic Acid (RNA) Probe Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 31.2. South America Ribonucleic Acid (RNA) Probe Market, Segmentation By Product Type, Segmentation By Technology, Segmentation By Delivery Method, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

32. Brazil Ribonucleic Acid (RNA) Probe Market

  • 32.1. Brazil Ribonucleic Acid (RNA) Probe Market, Segmentation By Product Type, Segmentation By Technology, Segmentation By Delivery Method, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

33. Middle East Ribonucleic Acid (RNA) Probe Market

  • 33.1. Middle East Ribonucleic Acid (RNA) Probe Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 33.2. Middle East Ribonucleic Acid (RNA) Probe Market, Segmentation By Product Type, Segmentation By Technology, Segmentation By Delivery Method, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

34. Africa Ribonucleic Acid (RNA) Probe Market

  • 34.1. Africa Ribonucleic Acid (RNA) Probe Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 34.2. Africa Ribonucleic Acid (RNA) Probe Market, Segmentation By Product Type, Segmentation By Technology, Segmentation By Delivery Method, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

35. Ribonucleic Acid (RNA) Probe Market Regulatory and Investment Landscape

36. Ribonucleic Acid (RNA) Probe Market Competitive Landscape And Company Profiles

  • 36.1. Ribonucleic Acid (RNA) Probe Market Competitive Landscape And Market Share 2024
    • 36.1.1. Top 10 Companies (Ranked by revenue/share)
  • 36.2. Ribonucleic Acid (RNA) Probe Market - Company Scoring Matrix
    • 36.2.1. Market Revenues
    • 36.2.2. Product Innovation Score
    • 36.2.3. Brand Recognition
  • 36.3. Ribonucleic Acid (RNA) Probe Market Company Profiles
    • 36.3.1. F. Hoffmann-La Roche Ltd. Overview, Products and Services, Strategy and Financial Analysis
    • 36.3.2. Thermo Fisher Scientific Inc. Overview, Products and Services, Strategy and Financial Analysis
    • 36.3.3. Merck KGaA Overview, Products and Services, Strategy and Financial Analysis
    • 36.3.4. Danaher Corporation Overview, Products and Services, Strategy and Financial Analysis
    • 36.3.5. Eurofins Scientific SE Overview, Products and Services, Strategy and Financial Analysis

37. Ribonucleic Acid (RNA) Probe Market Other Major And Innovative Companies

  • Agilent Technologies Inc., Revvity Inc., QIAGEN N.V., Bio-Techne Corporation, GenScript Biotech Corporation, Takara Bio Inc., RiboBio Co. Ltd., Bio-Synthesis Inc., Biotage AB, Biolegio B.V., Ella Biotech GmbH, Baseclick GmbH, Geno Technology Inc., Enzo Biochem Inc., LGC Biosearch Technologies

38. Global Ribonucleic Acid (RNA) Probe Market Competitive Benchmarking And Dashboard

39. Upcoming Startups in the Market

40. Key Mergers And Acquisitions In The Ribonucleic Acid (RNA) Probe Market

41. Ribonucleic Acid (RNA) Probe Market High Potential Countries, Segments and Strategies

  • 41.1 Ribonucleic Acid (RNA) Probe Market In 2030 - Countries Offering Most New Opportunities
  • 41.2 Ribonucleic Acid (RNA) Probe Market In 2030 - Segments Offering Most New Opportunities
  • 41.3 Ribonucleic Acid (RNA) Probe Market In 2030 - Growth Strategies
    • 41.3.1 Market Trend Based Strategies
    • 41.3.2 Competitor Strategies

42. Appendix

  • 42.1. Abbreviations
  • 42.2. Currencies
  • 42.3. Historic And Forecast Inflation Rates
  • 42.4. Research Inquiries
  • 42.5. The Business Research Company
  • 42.6. Copyright And Disclaimer
샘플 요청 목록
0 건의 상품을 선택 중
목록 보기
전체삭제
문의
원하시는 정보를
찾아 드릴까요?
문의주시면 필요한 정보를
신속하게 찾아드릴게요.
02-2025-2992
email
문의하기